(NASDAQ: PEPG) Pepgen's forecast annual revenue growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 49.33%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 11.84%.
Pepgen's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast PEPG's revenue for 2025 to be $651,262,825, with the lowest PEPG revenue forecast at $651,262,825, and the highest PEPG revenue forecast at $651,262,825. On average, 1 Wall Street analysts forecast PEPG's revenue for 2026 to be $2,442,072,616, with the lowest PEPG revenue forecast at $2,442,072,616, and the highest PEPG revenue forecast at $2,442,072,616.
In 2027, PEPG is forecast to generate $780,341,944 in revenue, with the lowest revenue forecast at $780,341,944 and the highest revenue forecast at $780,341,944.